pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
ICG-124
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
iCell Gene Therapeutics LLC
0
catalysts
Phase 2
ICT-01
Metastatic Melanoma
ImCheck Therapeutics SAS
0
catalysts
Preclinical
ICT-568
Thyroid Cancer
Innovative Cellular Therapeutics Co Ltd
0
catalysts
Phase 1
IDE-034
← prev
page 22 of 62
next →
131
Pain
89
Neurology
1
Castration-Resistant Prostate Cancer (CRPC)
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 2
IDE-161
Colon Cancer
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 2
IDE-275
Endometrial Cancer
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 2
IDE-397
Adenoid Cystic Carcinoma (ACC)
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 1
IDE-574
Breast Cancer
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 1
IDE-892
Esophageal Squamous Cell Carcinoma (ESCC)
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 1
IDOV-Immune
Solid Tumor
Viromissile Inc
0
catalysts
Phase 3
IFxHu-20
Merkel Cell Carcinoma
TuHURA Biosciences Inc
0
catalysts
Phase 2
IGV-001
Glioblastoma Multiforme (GBM)
Imvax Inc
0
catalysts
Phase 1
IKS-03
B-Cell Non-Hodgkin Lymphoma
Iksuda Therapeutics Ltd
0
catalysts
Preclinical
IKS-04
Bile Duct Cancer (Cholangiocarcinoma)
Iksuda Therapeutics Ltd
0
catalysts
Preclinical
IL-2106
Gastric Cancer
iLEAD Biomedical Science Inc
0
catalysts
Phase 1
IM-1021
Diffuse Large B-Cell Lymphoma
$IMNM
Immunome Inc.
0
catalysts
Preclinical
IM-1240
Adenocarcinoma Of The Gastroesophageal Junction
$PPBT
PURPLE BIOTECH LTD.
0
catalysts
Phase 1
IM-3050
Solid Tumor
$IMNM
Immunome Inc.
0
catalysts
Phase 2
IMA-203CD8
Solid Tumor
Immatics NV
0
catalysts
Phase 1
IMC-002
Solid Tumor
ImmuneOncia Therapeutics Inc
0
catalysts
Preclinical
IMC-008
Gastric Cancer
Suzhou Immunofoco Biotechnology Co Ltd
0
catalysts
Preclinical
IMM-4701
Triple-Negative Breast Cancer (TNBC)
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
0
catalysts
Phase 3
IMNN-001
Epithelial Ovarian Cancer
$IMNN
Imunon, Inc.
0
catalysts
Phase 2
IMP-1734
Fallopian Tube Cancer
$EIKN
Eikon Therapeutics, Inc.
0
catalysts
Phase 2
IMP-9064
Solid Tumor
IMPACT Therapeutics Inc
0
catalysts
Phase 2
IMT-009
Burkitt Lymphoma
Immunitas Therapeutics Inc
0
catalysts
Phase 2
IMU-131
Gastric Cancer
Imugene Ltd
0
catalysts
Phase 1
INB-100
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$INAB
IN8BIO, INC.
0
catalysts
Phase 1
INB-200
Glioblastoma Multiforme (GBM)
$INAB
IN8BIO, INC.
0
catalysts
Preclinical
INB-619
Systemic Lupus Erythematosus
$INAB
IN8BIO, INC.
0
catalysts
